EMN are trying but they arent close:
1: They have an after-tax NPV of US$593 million using a 10% discount rate, and an after-tax IRR of 22.6% and thats their whole business. We are ahead of the curve even without the HPM
2: $459.2 million in CAPEX for their project with a 4.5 year pay back. We are cash flow positive, ready to produce in 2024/25 and will likely be self funding and lower CAPEX from exsisting infrastucture
3: A positive for EMN is a very low OPEX per tonne of plant feed at at $111.28/T with HPEMM going at $4617 per tonne and HPMSM at $2666 per tonnes thats a nice margin.
E25 have a few more steps in that process operating at $150A$/dt Product so I assume higher OPEX however even at a high OPEX lets just pick a silly number like $500 per tonne you are still making $2000 per tonne on HPMSM and $4100 on HPEMM depending on what E25 are capbale of. Huge margins there if we can pull it off
- Forums
- ASX - By Stock
- Ann: Battery Grade HPMSM Processing Breakthrough
E25
element 25 limited
Add to My Watchlist
0.00%
!
22.5¢

EMN are trying but they arent close:1: They have an after-tax...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
22.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $51.43M |
Open | High | Low | Value | Volume |
22.5¢ | 22.5¢ | 21.5¢ | $21.94K | 100.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2779 | 21.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.5¢ | 62609 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2779 | 0.215 |
2 | 5119 | 0.210 |
2 | 8107 | 0.205 |
7 | 59405 | 0.200 |
3 | 13077 | 0.195 |
Price($) | Vol. | No. |
---|---|---|
0.225 | 62609 | 2 |
0.230 | 72958 | 1 |
0.235 | 24800 | 2 |
0.240 | 252084 | 2 |
0.245 | 21276 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
E25 (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online